27.04.2016
- US regulators have given a breakthrough designation to Bristol-Myers Squibb’s cancer drug Opdivo (nivolumab) for treating head and neck cancer. This is the fifth breakthrough...
14.04.2016
- Bristol-Myers Squibb’s cancer drug Opdivo can now be used to treat more patients with lung cancer or kidney cancer after European regulators expanded its indications. The EU...
